Werewolf Therapeutics (HOWL) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.98, -1.71% vs the prior close of $1.00.
- Volume 309.20K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
HOWL dips 1.7% to $0.98. Closed at $0.98, -1.71% vs the prior close of $1.00. Day range $0.97–$1.01, opened at $1.01.
HOWL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — HOWL dips 1.7% to $0.98
- Closed at $0.98, -1.71% vs the prior close of $1.00. Day range $0.97–$1.01, opened at $1.01.
- Volume was 309.20K shares, 0.0x its 50-day average of 8.46M — lighter than usual.
- Price is +16.4% vs its 50-day average ($0.84) and +48.2% vs its 200-day average ($0.66).
- 52-week range $0.27–$1.83; today's close sits at 46% of that range, 46.4% below the 52-week high.
Oct 15, 2026 — HOWL rises 1.7% to $1.00, a 1-month high
- Closed at $1.00, +1.73% vs the prior close of $0.98. Day range $0.96–$1.02, opened at $0.96.
- Volume was 426.20K shares, 0.1x its 50-day average of 8.46M — lighter than usual.
- Price is +20.0% vs its 50-day average ($0.83) and +51.2% vs its 200-day average ($0.66).
- 52-week range $0.27–$1.83; today's close sits at 47% of that range, 45.5% below the 52-week high.
Oct 14, 2026 — HOWL dips 1.1% to $0.98
- Closed at $0.98, -1.11% vs the prior close of $0.99. Day range $0.97–$1.02, opened at $0.99.
- Volume was 664.00K shares, 0.1x its 50-day average of 8.46M — lighter than usual.
- Price is +19.7% vs its 50-day average ($0.82) and +49.0% vs its 200-day average ($0.66).
- 52-week range $0.27–$1.83; today's close sits at 46% of that range, 46.4% below the 52-week high.
Oct 13, 2026 — HOWL rises 0.9% to $0.99, a 1-month high, 3 up days in a row
- Closed at $0.99, +0.92% vs the prior close of $0.98. Day range $0.97–$1.01, opened at $1.00.
- Volume was 353.20K shares, 0.0x its 50-day average of 8.46M — lighter than usual.
- Price is +22.8% vs its 50-day average ($0.81) and +51.1% vs its 200-day average ($0.66).
- 52-week range $0.27–$1.83; today's close sits at 46% of that range, 45.8% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 — HOWL ends flat (+0.2%) to $0.98
- Closed at $0.98, +0.20% vs the prior close of $0.98. Day range $0.96–$1.02, opened at $0.98.
- Volume was 811.20K shares, 0.1x its 50-day average of 8.50M — lighter than usual.
- Price is +23.5% vs its 50-day average ($0.79) and +50.1% vs its 200-day average ($0.65).
- 52-week range $0.27–$1.85; today's close sits at 45% of that range, 46.9% below the 52-week high.
Oct 9, 2026 — HOWL jumps 7.7% to $0.98
- Closed at $0.98, +7.69% vs the prior close of $0.91. Day range $0.92–$0.99, opened at $0.93.
- Volume was 704.60K shares, 0.1x its 50-day average of 8.50M — lighter than usual.
- Price is +25.3% vs its 50-day average ($0.78) and +50.2% vs its 200-day average ($0.65).
- 52-week range $0.27–$1.94; today's close sits at 43% of that range, 49.4% below the 52-week high.
Oct 8, 2026 — HOWL dips 1.1% to $0.91, 3 down days in a row
- Closed at $0.91, -1.09% vs the prior close of $0.92. Day range $0.91–$0.93, opened at $0.92.
- Volume was 631.30K shares, 0.1x its 50-day average of 8.51M — lighter than usual.
- Price is +17.8% vs its 50-day average ($0.77) and +39.8% vs its 200-day average ($0.65).
- 52-week range $0.27–$2.13; today's close sits at 34% of that range, 57.3% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — HOWL ends flat (+0.0%) to $0.92
- Closed at $0.92, +0.00% vs the prior close of $0.92. Day range $0.91–$0.93, opened at $0.92.
- Volume was 381.60K shares, 0.0x its 50-day average of 8.50M — lighter than usual.
- Price is +20.5% vs its 50-day average ($0.76) and +41.6% vs its 200-day average ($0.65).
- 52-week range $0.27–$2.13; today's close sits at 35% of that range, 56.8% below the 52-week high.
Oct 6, 2026 — HOWL dips 1.1% to $0.92
- Closed at $0.92, -1.08% vs the prior close of $0.93. Day range $0.91–$0.94, opened at $0.94.
- Volume was 278.20K shares, 0.0x its 50-day average of 8.51M — lighter than usual.
- Price is +22.0% vs its 50-day average ($0.75) and +41.9% vs its 200-day average ($0.65).
- 52-week range $0.27–$2.15; today's close sits at 35% of that range, 57.2% below the 52-week high.
Oct 5, 2026 — HOWL ends flat (+0.2%) to $0.93
- Closed at $0.93, +0.22% vs the prior close of $0.93. Day range $0.91–$0.95, opened at $0.93.
- Volume was 237.70K shares, 0.0x its 50-day average of 8.56M — lighter than usual.
- Price is +24.8% vs its 50-day average ($0.74) and +43.3% vs its 200-day average ($0.65).
- 52-week range $0.27–$2.15; today's close sits at 35% of that range, 56.7% below the 52-week high.
Oct 2, 2026 — HOWL jumps 5.2% to $0.93
- Closed at $0.93, +5.22% vs the prior close of $0.88. Day range $0.89–$0.94, opened at $0.89.
- Volume was 470.90K shares, 0.1x its 50-day average of 8.56M — lighter than usual.
- Price is +26.3% vs its 50-day average ($0.73) and +42.8% vs its 200-day average ($0.65).
- 52-week range $0.27–$2.15; today's close sits at 35% of that range, 56.8% below the 52-week high.
HOWL latest news & SEC filings
Every SEC filing by or about HOWL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 21, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Jul 31, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $3.67M (prior year -$17.98M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.08 (prior year -$0.40) (swung to profit vs Jun 30, 2025)
Jul 31, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Evnin Luke sold 107,429 shares at $0.31 (≈$33.30K) on Jul 7, 2026
- Evnin Luke sold 107,429 shares at $0.31 (≈$33.30K) on Jul 7, 2026
- Evnin Luke sold 107,429 shares at $0.31 (≈$33.30K) on Jul 7, 2026
- Evnin Luke sold 107,429 shares at $0.31 (≈$33.30K) on Jul 7, 2026
- Evnin Luke sold 35,770 shares at $0.32 (≈$11.45K) on Jul 6, 2026
- Evnin Luke sold 35,770 shares at $0.32 (≈$11.45K) on Jul 6, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 6, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 6, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 6, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 6, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 6, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 2, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 26, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade HOWL
- Last results release: Jul 31, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 27, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Oct 30, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.87% (largest 7.7%).
- Liquidity: about 495.72K shares (≈$485.81K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.98 vs a range of $0.27–$1.83 (46% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Luke Evnin sold 107,429 shares on Jul 7, 2026.
- Latest filings: 8-K Aug 21, 2026; 8-K Aug 20, 2026; 10-Q Jul 31, 2026.
- Share count: 48.60M shares outstanding (Jul 27, 2026), +6.3% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
HOWL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.01 | 1.01 | 0.97 | 0.98 | 309.20K |
| Oct 15, 2026 | 0.96 | 1.02 | 0.96 | 1.00 | 426.20K |
| Oct 14, 2026 | 0.99 | 1.02 | 0.97 | 0.98 | 664.00K |
| Oct 13, 2026 | 1.00 | 1.01 | 0.97 | 0.99 | 353.20K |
| Oct 12, 2026 | 0.98 | 1.02 | 0.96 | 0.98 | 811.20K |
| Oct 9, 2026 | 0.93 | 0.99 | 0.92 | 0.98 | 704.60K |
| Oct 8, 2026 | 0.92 | 0.93 | 0.91 | 0.91 | 631.30K |
| Oct 7, 2026 | 0.92 | 0.93 | 0.91 | 0.92 | 381.60K |
| Oct 6, 2026 | 0.94 | 0.94 | 0.91 | 0.92 | 278.20K |
| Oct 5, 2026 | 0.93 | 0.95 | 0.91 | 0.93 | 237.70K |
| Oct 2, 2026 | 0.89 | 0.94 | 0.89 | 0.93 | 470.90K |
| Oct 1, 2026 | 0.92 | 0.93 | 0.88 | 0.88 | 299.00K |
| Sep 30, 2026 | 0.91 | 0.94 | 0.89 | 0.92 | 828.20K |
| Sep 29, 2026 | 0.94 | 0.95 | 0.88 | 0.91 | 970.50K |
| Sep 28, 2026 | 0.97 | 0.97 | 0.93 | 0.93 | 699.30K |
| Sep 25, 2026 | 0.98 | 0.98 | 0.96 | 0.96 | 454.90K |
| Sep 24, 2026 | 0.99 | 0.99 | 0.97 | 0.98 | 227.50K |
| Sep 23, 2026 | 0.97 | 0.99 | 0.97 | 0.99 | 316.50K |
| Sep 22, 2026 | 0.99 | 1.00 | 0.97 | 0.98 | 374.80K |
| Sep 21, 2026 | 0.99 | 0.99 | 0.96 | 0.98 | 475.60K |
About Werewolf Therapeutics
Werewolf Therapeutics (HOWL) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in WALTHAM, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1785530.
HOWL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Luke Evnin | Director | Jul 8, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael J. Urban | VP of Finance & Corp. Contr. | Mar 13, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 7, 2026 | Luke Evnin | Sale | 107,429 | $0.31 |
| Jul 7, 2026 | Luke Evnin | Sale | 107,429 | $0.31 |
| Jul 7, 2026 | Luke Evnin | Sale | 107,429 | $0.31 |
| Jul 7, 2026 | Luke Evnin | Sale | 107,429 | $0.31 |
| Jul 6, 2026 | Luke Evnin | Sale | 35,770 | $0.32 |
| Jul 6, 2026 | Luke Evnin | Sale | 35,770 | $0.32 |
| Jul 6, 2026 | Luke Evnin | Sale | 35,770 | $0.32 |
| Jul 6, 2026 | Luke Evnin | Sale | 35,770 | $0.32 |
| Jun 29, 2026 | Luke Evnin | Sale | 157,084 | $0.30 |
| Jun 29, 2026 | Luke Evnin | Sale | 157,084 | $0.30 |
| Jun 29, 2026 | Luke Evnin | Sale | 157,084 | $0.30 |
| Jun 29, 2026 | Luke Evnin | Sale | 157,084 | $0.30 |
| Jun 17, 2026 | Capital Management, L.P. Ra | Sale | 389,216 | $0.35 |
| Jun 17, 2026 | Capital Management, L.P. Ra | Sale | 27,695 | $0.35 |
| Jun 17, 2026 | Capital Management, L.P. Ra | Sale | 389,216 | $0.35 |
HOWL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-60.82M | -1.33 | $-60.29M |
| Dec 31, 2024 | — | $-70.52M | -1.63 | $-56.19M |
| Dec 31, 2023 | — | $-37.37M | -1.05 | $-32.61M |
| Dec 31, 2022 | — | $-53.81M | -1.86 | $-40.60M |
| Dec 31, 2021 | — | $-49.98M | -10.94 | $-42.88M |
Latest balance sheet: total assets $24.16M, total liabilities $7.86M, cash $21.99M (as of Jun 30, 2026).
HOWL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 31, 2026 | 8-K Item 2.02 (results) | $0.35 |
| May 7, 2026 | 8-K Item 2.02 (results) | $0.62 |
| Mar 27, 2026 | 8-K Item 2.02 (results) | $0.78 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $1.21 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $1.32 |
| May 8, 2025 | 8-K Item 2.02 (results) | $0.87 |
| Mar 11, 2025 | 8-K Item 2.02 (results) | $1.26 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $2.24 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 3, 2024 | 8-K Item 2.02 (results) | — |
| Mar 7, 2024 | 8-K Item 2.02 (results) | — |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on HOWL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.